FindTrial
Sign In

Seroprevalence of Varicella antibodies in children and adolescents with Nephrotic Syndrome

Seroprevalence of Varicella antibodies in children and adolescents with Nephrotic Syndrome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071198
Enrollment
100
Registered
2024-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N04- Nephrotic syndrome

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Department of Paediatrics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children and adolescents with Nephrotic syndrome who are in remission

Exclusion criteria

Exclusion criteria: Patients with congenital nephrotic syndrome

Design outcomes

Primary

MeasureTime frame
IgG antibody titres against varicella in children and adolescents with steroid sensitive and steroid resistant nephrotic syndrome in disease remissionTimepoint: Patients in disease remission—

Secondary

MeasureTime frame
Association of antibody titres with disease type, duration, immunosuppressive treatment, past vaccination/varicella infectionTimepoint: Patients in disease remission—

Countries

India

Contacts

Public ContactDr.Mukta Mantan

Maulana Azad Medical College

muktamantan@hotmail.com9968604315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026